Search Ontology:
ChEBI

SN50

Term ID
CHEBI:195371
Synonyms
  • AAVALLPAVLLALLAPVQRKRQKLMP
  • H-AAVALLPAVLLALLAPVQRKRQKLMP-OH
  • H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH
  • L-Ala-L-Ala-L-Val-L-Ala-L-Leu-L-Leu-L-Pro-L-Ala-L-Val-L-Leu-L-Leu-L-Ala-L-Leu-L-Leu-L-Ala-L-Pro-L-Val-L-Gln-L-Arg-L-Lys-L-Arg-L-Gln-L-Lys-L-Leu-L-Met-L-Pro
  • L-alanyl-L-alanyl-L-valyl-L-alanyl-L-leucyl-L-leucyl-L-prolyl-L-alanyl-L-valyl-L-leucyl-L-leucyl-L-alanyl-L-leucyl-L-leucyl-L-alanyl-L-prolyl-L-valyl-L-glutaminyl-L-arginyl-L-lysyl-L-arginyl-L-glutaminyl-L-lysyl-L-leucyl-L-methionyl-L-proline
  • NF-kappaB SN50
  • SN 50
  • SN-50
Definition
A 26-amino acid peptide with formula C129H230N36O29S. It is a cell permeable inhibitor of NF-κB translocation.
References
  • cas:213546-53-3
  • patent:AU2008303928
  • patent:EP2197469
  • pubmed:11376325
  • pubmed:15205451
  • pubmed:15855640
  • pubmed:18437038
  • pubmed:19398609
  • pubmed:21614693
  • pubmed:22437493
  • pubmed:23584794
  • pubmed:24482641
  • pubmed:24557012
  • pubmed:24646628
  • pubmed:26780513
  • pubmed:29166808
  • pubmed:30868916
  • pubmed:31420372
  • pubmed:32269680
  • pubmed:32291991
  • pubmed:32460750
  • pubmed:34274951
  • pubmed:36691058
  • pubmed:36982949
  • pubmed:37001840
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from SN50
Phenotype where environments contain SN50
Phenotype modified by environments containing SN50
Phenotype affecting SN50
Human Disease Model